Lind M - Search Results

1

Steady-state plasma concentrations of alprenolol in man.

Rawlins MD, Collste P, Frisk-Holmberg M, Lind M, Ostman J, Sjöqvist F. Rawlins MD, et al. Among authors: lind m. Eur J Clin Pharmacol. 1974 Aug 23;7(5):353-6. doi: 10.1007/BF00558205. Eur J Clin Pharmacol. 1974. PMID: 4419005 No abstract available.

2

Plasma disappearance of nortriptyline in a newborn infant following placental transfer from an intoxicated mother: evidence for drug metabolism.

Sjöqvist F, Bergfors PG, Borgå O, Lind M, Ygge H. Sjöqvist F, et al. Among authors: lind m. J Pediatr. 1972 Mar;80(3):496-500. doi: 10.1016/s0022-3476(72)80516-x. J Pediatr. 1972. PMID: 5017806 No abstract available.

3

The debrisoquin hydroxylation phenotype does not predict the metabolism of phenytoin.

Steiner E, Alván G, Garle M, Maguire JH, Lind M, Nilson SO, Tomson T, McClanahan JS, Sjöqvist F. Steiner E, et al. Among authors: lind m. Clin Pharmacol Ther. 1987 Sep;42(3):326-33. doi: 10.1038/clpt.1987.156. Clin Pharmacol Ther. 1987. PMID: 3621788

4

Effect of pentobarbital on the disposition of alprenolol.

Alván G, Piafsky K, Lind M, von Bahr C. Alván G, et al. Among authors: lind m. Clin Pharmacol Ther. 1977 Sep;22(3):316-21. doi: 10.1002/cpt1977223316. Clin Pharmacol Ther. 1977. PMID: 891097

5

Proceedings: "First-pass" effect and dose dependent availability as factors contributing to interindividual differences in equilibrium concentrations of alprenolol in man.

Bahr C, Alván G, Lind M, Mellström B, Sjöqvist V. Bahr C, et al. Among authors: lind m. Acta Pharm Suec. 1974 Dec;11(6):649-50. Acta Pharm Suec. 1974. PMID: 1136801 No abstract available.

6

First pass hydroxylation of nortriptyline: concentrations of parent drug and major metabolites in plasma.

Alván G, Borga O, Lind M, Palmér L, Siwers B. Alván G, et al. Among authors: lind m. Eur J Clin Pharmacol. 1977 Mar 11;11(3):219-24. doi: 10.1007/BF00606414. Eur J Clin Pharmacol. 1977. PMID: 852498

7

Plasma and salivary pharmacokinetics of caffeine in man.

Newton R, Broughton LJ, Lind MJ, Morrison PJ, Rogers HJ, Bradbrook ID. Newton R, et al. Among authors: lind mj. Eur J Clin Pharmacol. 1981;21(1):45-52. doi: 10.1007/BF00609587. Eur J Clin Pharmacol. 1981. PMID: 7333346

8

Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol.

Alván G, Lind M, Mellström B, von Bahr C. Alván G, et al. Among authors: lind m. J Pharmacokinet Biopharm. 1977 Jun;5(3):193-205. doi: 10.1007/BF01065395. J Pharmacokinet Biopharm. 1977. PMID: 881641 No abstract available.

9

Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing.

Lindholm A, Henricsson S, Lind M, Dahlqvist R. Lindholm A, et al. Among authors: lind m. Eur J Clin Pharmacol. 1988;34(5):461-4. doi: 10.1007/BF01046702. Eur J Clin Pharmacol. 1988. PMID: 3203705

10

On the question of dose-dependent chloroquine elimination of a single oral dose.

Gustafsson LL, Rombo L, Alván G, Björkman A, Lind M, Walker O. Gustafsson LL, et al. Among authors: lind m. Clin Pharmacol Ther. 1983 Sep;34(3):383-5. doi: 10.1038/clpt.1983.183. Clin Pharmacol Ther. 1983. PMID: 6883914 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,189 results

Search Page

Filters